Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: May 15, 2026

Isolation, Enrichment, and Maintenance of Medulloblastoma Stem Cells
06:32

Isolation, Enrichment, and Maintenance of Medulloblastoma Stem Cells

Published on: September 1, 2010

Medulloblastoma.

F Bartlett1, R Kortmann, F Saran

  • 1Department of Radiotherapy, The Royal Marsden NHS Foundation Trust, Sutton, Surrey, UK.

Clinical Oncology (Royal College of Radiologists (Great Britain))
|December 19, 2012
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Feasibility and Outcomes of Craniospinal Irradiation and Concurrent Daily Carboplatin in Children and Adults With High-risk Central Nervous System Tumours.

Clinical oncology (Royal College of Radiologists (Great Britain))·2025
Same author

Predicting Survival with Brain Metastases in the Stereotactic Radiosurgery Era: are Existing Prognostic Scores Still Relevant? Or Can we do Better?

Clinical oncology (Royal College of Radiologists (Great Britain))·2024
Same author

Hypofractionated Stereotactic Ablative Radiotherapy for Recurrent or Oligometastatic Tumours in Children and Young Adults.

Clinical oncology (Royal College of Radiologists (Great Britain))·2019
Same author

Challenges to Treating Older Glioblastoma Patients: the Influence of Clinical and Tumour Characteristics on Survival Outcomes.

Clinical oncology (Royal College of Radiologists (Great Britain))·2017
Same author

Stereotactic radiosurgery planning of vestibular schwannomas: Is MRI at 3 Tesla geometrically accurate?

Medical physics·2016
Same author

Validating a robust double-quantum-filtered (1) H MRS lactate measurement method in high-grade brain tumours.

NMR in biomedicine·2016
Same journal

Research Trends in Physical Activity and Breast Cancer: A 25-Year Bibliometric Analysis (2000-2025).

Clinical oncology (Royal College of Radiologists (Great Britain))·2026
Same journal

Concordance Between Planned and Delivered treatment for Head and Neck Cancer Patients Treated With Curative Intent: A Real-World Comparison of Under 70-year-olds With 70-year-olds and Over.

Clinical oncology (Royal College of Radiologists (Great Britain))·2026
Same journal

A Novel Technique for Pain Management to Deliver a Course of Palliative Radiotherapy.

Clinical oncology (Royal College of Radiologists (Great Britain))·2026
Same journal

Broad-Spectrum Antibiotics are Associated with worse Survival After Radical Treatment for Glioblastoma Multiforme: A Multicentre Study.

Clinical oncology (Royal College of Radiologists (Great Britain))·2026
Same journal

Exploring the Need for Plan Adaptation in Robustly Optimised Head and Neck Intensity Modulated Proton Therapy: A Dosimetric Perspective From Initial Institutional Experience.

Clinical oncology (Royal College of Radiologists (Great Britain))·2026
Same journal

Lifting the Lid on Best Practice in a Case of Oligometastatic Breast Cancer.

Clinical oncology (Royal College of Radiologists (Great Britain))·2026
See all related articles

Medulloblastomas, the most common childhood brain tumors, are increasingly understood through molecular advances. Treatment combines surgery, radiation, and chemotherapy, with future therapies aiming for personalized, quality-of-life-focused care.

Area of Science:

  • Neuro-oncology
  • Pediatric oncology
  • Molecular genetics

Background:

  • Medulloblastomas are primary malignant embryonal tumors of the central nervous system, predominantly affecting children.
  • They typically arise in the cerebellum, causing symptoms of increased intracranial pressure.
  • While classical and desmoplastic subtypes are most common, molecular advances are refining understanding and classification.

Purpose of the Study:

  • To review current understanding of medulloblastoma, including histology, molecular genetics, and staging.
  • To outline the multimodality treatment approach and recent advancements in surgical, radiotherapeutic, and chemotherapeutic strategies.
  • To discuss future directions in personalized treatment and quality of life for medulloblastoma patients.

Main Methods:

More Related Videos

Intracranial Orthotopic Allografting of Medulloblastoma Cells in Immunocompromised Mice
05:10

Intracranial Orthotopic Allografting of Medulloblastoma Cells in Immunocompromised Mice

Published on: October 3, 2010

Related Experiment Videos

Last Updated: May 15, 2026

Isolation, Enrichment, and Maintenance of Medulloblastoma Stem Cells
06:32

Isolation, Enrichment, and Maintenance of Medulloblastoma Stem Cells

Published on: September 1, 2010

Intracranial Orthotopic Allografting of Medulloblastoma Cells in Immunocompromised Mice
05:10

Intracranial Orthotopic Allografting of Medulloblastoma Cells in Immunocompromised Mice

Published on: October 3, 2010

  • Review of current literature on medulloblastoma diagnosis, staging, and treatment.
  • Analysis of recent advances in molecular biology and cytogenetics.
  • Evaluation of multimodality treatment strategies including surgery, radiotherapy, and chemotherapy.

Main Results:

  • Improved understanding of medulloblastoma subtypes and their relation to patient outcomes through molecular and cytogenetic analysis.
  • Advances in surgical techniques and radiotherapy have optimized tumor control and reduced toxicity.
  • Multimodality treatment has led to improved survival rates across patient groups over the past two decades.

Conclusions:

  • Medulloblastoma treatment is evolving towards individualized approaches based on genetic profiles.
  • Future strategies will focus on enhancing survival while prioritizing patient quality of life.
  • Continued research into molecular drivers and targeted therapies is crucial for advancing care.